- Encysive Pharmaceuticals Blind-Sided: Thelin Receives Approvable Letter from FDA
- FDA Delay of Tysabri Verdict Not a Surprise (BIIB, ELN)
- Nabi Biopharmaceuticals Continues Clinical Development of StaphVax (NABI)
- Tysabri Comes Out On Top At FDA Panel Meeting (BIIB, ELN)
- Tysabri To Be Discussed At FDA Advisory Committee Meeting: Findings From The Briefing Documents (BIIB, ELN)
BioBlogger
BioBlogger
Stop FollowingBioBlogger
ABOUT
BioBlogger is a contributor to Seeking Alpha.
SNAPSHOT
This area is reserved for BioBlogger's:
- Self-description
- Trading frequency
- Interests
Users can update their snapshots by editing their profiles via Settings.
COMPANY
Currently, there is no company profile for BioBlogger.
BLOG
Currently, there are no blog details for BioBlogger.
Book
Currently, there are no book details for BioBlogger.
Latest comments on BioBlogger's Articles
- dipika on Welcome To The Biotech Stock Blog
- markettips1 on Welcome To The Biotech Stock Blog
- UserThunderBolt on Research Report Highlights Reality of Tysabri’s...
- avian on BioCryst and Avian Flu: Underappreciated Call O...
- BioBlogger_ on Tysabri Comes Out On Top At FDA Panel Meeting (...
LATEST ARTICLES & INSTAPOSTS
more »
